Full identifier: http://purl.org/np/RAdcjjIm7IPqDx73bG45CqnDcWPPhnYQ6cs1d7OSGZGik#LACDR-DDS-CTDS
Assigned to 1 class:
Described in 1 nanopublication:
| Nanopublication | Part | Subject | Predicate | Object | Published By | Published On |
|---|---|---|---|---|---|---|
|
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
FIP Wizard
|
2023-07-13T21:28:24.000Z
|
|||
|
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
LACDR DDS CTDS | Cancer Therapeutics and Drug Safety, Division of Drug Discovery & Safety, LACDR, Leiden University
|
FIP Wizard
|
2023-07-13T21:28:24.000Z
|
||
|
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
FIP Wizard
|
2023-07-13T21:28:24.000Z
|
|||
|
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
FIP Wizard
|
2023-07-13T21:28:24.000Z
|
|||
|
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
FIP Wizard
|
2023-07-13T21:28:24.000Z
|
|||
|
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
In the Cancer Therapeutics and Drug Safety research group at the LACDR, headed by prof. dr. Bob van de Water, cell signaling programs that underlie adverse drug reactions as well as cancer development and progression are unraveled.
|
FIP Wizard
|
2023-07-13T21:28:24.000Z
|
||
|
links a nanopublication to its pubinfo
http://www.nanopub.org/nschema#hasPublicationInfo
pubinfo
|
LACDR-DDS-CTDS
|
FIP Wizard
|
2023-07-13T21:28:24.000Z
|